about
EQ-5D studies in musculoskeletal and connective tissue diseases in eight Central and Eastern European countries: a systematic literature review and meta-analysis.Long-term costs and survival of prostate cancer: a population-based study.Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L in psoriasis patients.Is the DLQI appropriate for medical decision-making in psoriasis patients?Validity of the EQ-5D-5L and EQ-5D-3L in patients with Crohn’s diseaseThe burden of informal caregiving in Hungary, Poland and Slovenia: results from national representative surveys.Subjective well-being in patients with pemphigus: a path analysis.Towards a Central-Eastern European EQ-5D-3L population norm: comparing data from Hungarian, Polish and Slovenian population studies.Determinants of the acceptability of health problems in different ages: exploring a new application of the EQ VAS.A comparison of European, Polish, Slovenian and British EQ-5D-3L value sets using a Hungarian sample of 18 chronic diseases.Subjective expectations regarding ageing: a cross-sectional online population survey in Hungary.Validity of the EQ-5D in patients with pemphigus vulgaris and pemphigus foliaceusProposal of a new scoring formula for the Dermatology Life Quality Index in psoriasisDevelopment of Population Tariffs for the CarerQol Instrument for Hungary, Poland and Slovenia: A Discrete Choice Experiment Study to Measure the Burden of Informal CaregivingLong-Term Efficacy of Tumor Necrosis Factor Inhibitors for the Treatment of Methotrexate-Naïve Rheumatoid Arthritis: Systematic Literature Review and Meta-AnalysisPatient-assigned health utility values for controlled and uncontrolled pemphigus vulgaris and foliaceusTime to revise the Dermatology Life Quality Index scoring in psoriasis treatment guidelinesEQ-5D studies in nervous system diseases in eight Central and East European countries: a systematic literature reviewPsychometric properties of the Hungarian version of the eHealth Literacy ScalePatient experiences with outpatient care in Hungary: results of an online population surveyUnmet medical needs in ambulatory care in Hungary: forgone visits and medications from a representative population surveyPatient and general population values for luminal and perianal fistulising Crohn's disease health statesCost-of-illness studies in nine Central and Eastern European countriesLong-term efficacy and cost-effectiveness of infliximab as first-line treatment in rheumatoid arthritis: systematic review and meta-analysisValidity and reliability of the 9-item Shared Decision Making Questionnaire (SDM-Q-9) in a national survey in HungaryDLQI-R scoring improves the discriminatory power of the Dermatology Life Quality Index in patients with psoriasis, pemphigus and morpheaDisease burden of patients with pemphigus from a societal perspectiveCapability of well-being: validation of the Hungarian version of the ICECAP-A and ICECAP-O questionnaires and population normative data
P50
Q38636348-23F127B1-5E9F-47FD-8AF3-3B74214DC132Q38650062-02447F23-E35D-46E5-AAA8-7B4986149523Q48123615-36BEE810-C211-402C-8147-48001E7E5F47Q48320518-E661DA56-28BD-4C08-A47E-F21FF008E20AQ57089296-4684A138-5E7A-4073-B647-06F116AD35C6Q64904367-D7F6DCA1-104C-4B55-B2BC-6D56F5CAD701Q64944030-026DFAB5-356B-49A0-B19E-9BE92176925CQ64968601-12C17A0E-539E-4FF8-8B7E-209A3FFFC048Q64971484-06E52A82-D4F7-4C57-A40A-EF1B30F00338Q64981700-08243BF5-A695-45E4-88D4-BF1FC7765A9EQ65001028-85A197BA-6465-46FB-B365-54E7372866C0Q89089005-993093CB-8698-4B93-9A4A-7DB64610A692Q89397958-C691B87D-56AB-4AF6-A2BB-01AE51B11F70Q90580467-C0D0B7BA-10E4-4A10-ACF1-0FA09857EB52Q91021980-B9EA7E6A-A126-4519-BA83-EE2BEF2E5D0FQ91550110-B67F33AB-46D7-4C4E-B2D0-D58254F28913Q92030253-2D452711-FAA1-491A-948D-DC7076FF9545Q92102042-D2B57146-3FC1-49D5-8DFD-4ADD6DE91471Q92102051-A470C051-DC15-4197-9DB2-BBD504263D71Q92102071-81A0E9A4-2B53-443B-B788-A68B78D5A8CAQ92127842-7BB9372E-7529-48FE-8847-9A8417E7666FQ92127847-B419233C-7C3C-455F-96B9-90B2A95F897FQ92139201-7EA089E4-91B7-42E5-A67B-6113F3940C4FQ92151206-222D30DF-D8FE-4373-A76F-3673F405D975Q92180530-B88E8E95-E276-4A29-8084-4007B7CDF181Q92661168-3031017A-E219-4E98-8D5B-652E36D766EEQ92916655-A373B427-194F-436D-B7F0-30B55DF073AAQ95938889-1764849C-7F71-4E8F-A93A-AE96FC6A0C1E
P50
description
researcher
@en
wetenschapper
@nl
name
Márta Péntek
@en
Márta Péntek
@nl
type
label
Márta Péntek
@en
Márta Péntek
@nl
prefLabel
Márta Péntek
@en
Márta Péntek
@nl
P31
P496
0000-0001-9636-6012